Antonio Falcone Overview
- Firm
- Utopia SIS
- Primary Position
-
Chief Executive...
- Primary Industry
-
Healthcare
- Active Board Seats
-
2
- Med. Deal Size
-
- Med. Valuation
-
Antonio Falcone General Information
Biography
Mr. Antonio Falcone serves as Chief Executive Officer at Utopia SIS. He serves as a Board Member at T-One Therapeutics. He serves as a Board Member at CaSRevolution. He serves as Executive Vice President at Utopia Genesis Foundation. He served as Chief Investment Officer at Cube Labs. He served as Chief Executive Officer, Vice President, and Board Member at Principia SGR. Previously, he held the position of Area Manager at Axa Investment and Fund Manager at Unicredit, Banca Sella Group, and Deutsche Bank. From 2004 to 2010 he was Director of Investments for Inarcassa and three times winner of the IPE Award as Best Fund Manager in Europe. He was also a member of the asset location committee of Kairos SGR and a member of the advisory board of Ambienta SGR.
Contact Information
Address
- Via Paolo Nanni Costa
- 40133 Bologna
- Italy
Antonio Falcone Positions (2)
| Firm name | Firm type | Title | Location | Industry | Since |
|---|---|---|---|---|---|
| Utopia Genesis Foundation | Investor | Executive Vice President | Acquirer | ||
| Utopia SIS | Investor | Chief Executive Officer | Bologna, Italy | Venture Capital |
Antonio Falcone Board Seats (2)
| Company | Industry | Ownership Status | Financing Status | Location | Since |
|---|---|---|---|---|---|
| CaSRevolution | Biotechnology | Privately Held (backing) | Venture Capital-Backed | Milan, Italy | |
| T-One Therapeutics | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Milan, Italy |
Antonio Falcone Lead Partner on Deals (11)
Antonio Falcone has been the lead partner on 11 deals. Their latest deal was with CaSRevolution, a biotechnology company. The deal was made for on 23-Feb-2024.
| Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
|---|---|---|---|---|---|---|
| CaSRevolution | 23-Feb-2024 | Seed Round | Completed | Biotechnology | Milan, Italy | |
| CaSRevolution | 24-May-2023 | Completed | Biotechnology | Milan, Italy | ||
| Drug Discovery and Clinic | 17-Nov-2022 | Completed | Drug Discovery | Turin, Italy | ||
| T-One Therapeutics | 26-Sep-2022 | Completed | Drug Discovery | Milan, Italy | ||
| PerFormS | 16-Mar-2022 | Completed | Other Devices and Supplies | Modena, Italy | ||
| Lighthouse Biotech | 29-Dec-2021 | Completed | Drug Discovery | Pordenone, Italy | ||
| Clinical Trial Center | 07-Aug-2017 | Completed | Drug Discovery | Rome, Italy | ||
| Trifarma | 16-Jul-2017 | Completed | Pharmaceuticals | Milan, Italy | ||
| WISE (Diagnostic Equipment) | 25-May-2017 | Later Stage VC (Series B) | Completed | Diagnostic Equipment | Milan, Italy | |
| KLISBio | 21-Apr-2016 | Early Stage VC (Series A) | Completed | Therapeutic Devices | Milan, Italy |
Antonio Falcone Network (56)
Board Members (17)
| Name | Company | Representing | Location | From |
|---|---|---|---|---|
| Massimo Rossi | T-One Therapeutics | Self | Milan, Italy | |
| Eugenio Guglielmelli | Xyence | Xyence | Milan, Italy | |
| CaSRevolution | CaSRevolution | Milan, Italy | ||
| T-One Therapeutics | Self | Milan, Italy | ||
| Xyence | Self | Milan, Italy |
Portfolio Executives (33)
| Name | Company | Role | Deal date | Location |
|---|---|---|---|---|
| Mario Pellegatti | CaSRevolution | Co-Founder, Board Member & Head of Drug Development | 23-Feb-2024 | Milan, Italy |
| Gabriele Grecchi | CaSRevolution | Co-Founder & Board Member | 23-Feb-2024 | Milan, Italy |
| Drug Discovery and Clinic | Co-Founder and Board Member | 17-Nov-2022 | Turin, Italy | |
| Drug Discovery and Clinic | Chief Operating Officer | 17-Nov-2022 | Turin, Italy | |
| Drug Discovery and Clinic | Co-Founder and Chief Executive Officer | 17-Nov-2022 | Turin, Italy |
Fund Team Members (6)
| Name | Investor | Fund | Fund Location |
|---|---|---|---|
| Andrea Pederzolli | Xyence | Principia III - Health | Milan, Italy |
| Paolo Siviero | Xyence | Principia III - Health | Milan, Italy |
| Xyence | Milan, Italy | ||
| Xyence | Milan, Italy | ||
| Xyence | Milan, Italy |
Antonio Falcone Affiliated Funds (1)
| Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
|---|---|---|---|---|---|---|---|---|
| Principia III - Health | Xyence | Venture - General | Closed | 2015 |
Antonio Falcone FAQs
-
Who is Antonio Falcone?
Mr. Antonio Falcone serves as Chief Executive Officer at Utopia SIS.
-
How much does Antonio Falcone typically invest?
Antonio Falcone's median deal size is .
-
What is Antonio Falcone’s main position?
Antonio Falcone’s primary position is Chief Executive Officer.
-
What are the contact details for Antonio Falcone?
Antonio Falcone’s email address is a. and his phone number is +39 02 .
-
How many active board seats does Antonio Falcone hold?
Antonio Falcone holds 2 board seats including CaSRevolution and T-One Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
